Dong G, Broker T R, Chow L T
Department of Biochemistry, University of Rochester School of Medicine and Dentistry, New York 14642.
J Virol. 1994 Feb;68(2):1115-27. doi: 10.1128/JVI.68.2.1115-1127.1994.
The E6 promoter of human papillomaviruses (HPVs) trophic for epithelia for the lower genital tract and the upper respiratory tract is regulated in vitro by homologous and heterologous papillomaviral E2 proteins that bind to a consensus responsive sequence (E2-RS) ACCN6GGT. When HPV type 11 (HPV-11) expression is examined in epithelial cell lines, the HPV-11 E2-C protein, which lacks the amino-terminal transactivating domain of the full-length E2 protein, invariably represses the homologous viral E6 promoter. In contrast, when the novel constitutive enhancer (CE) CE II is deleted, not only is the basal promoter activity much reduced, it is further repressed by the intact HPV-11 E2 protein (M. T. Chin, T. R. Broker, and L. T. Chow, J. Virol. 63:2967-2976, 1989). Here, we demonstrated that, when expressed from a stronger surrogate promoter, the HPV-11 E2 protein represses the E6 promoter effectively, regardless of CE II. By performing systematic mutational analyses of the four highly conserved copies of the HPV-11 E2-RS and of the adjacent enhancer-promoter elements, we show that the furthest upstream, promoter-distal E2-RS copy 1 plays no apparent role in E6 promoter regulation. Repression by the homologous HPV-11 E2 proteins is mediated through each of the three promoter-proximal copies of the E2-RS, but the presence of CE II abrogates the full-length E2 protein repression exerted at E2-RS copy 2. Repression is alleviated when the two (for E2) or three (for E2-C) promoter-proximal copies of E2-RS are mutated. We specifically demonstrate that repression exerted at E2-RS 3 is due to preclusion of binding of the host transcription factor Sp1 or Sp1-like proteins to a nonconsensus sequence AGGAGG located 1 bp upstream of the tandem E2 protein binding sites 3 and 4. A 3-bp insertion between the adjacent Sp1 and E2-RS 3 sites permits both Sp1 and E2 proteins to bind, with a concomitant relief of E2-RS 3-mediated repression. Similar mutational analyses show that proteins that bind to the GT-1 motif near the upstream E2-RS 2 help abrogate repression by the E2 protein in the presence of CE II. The implications of these results with respect to the viral infectious cycle and during viral oncogenesis are discussed.
人乳头瘤病毒(HPV)的E6启动子对下生殖道和上呼吸道上皮具有嗜性,在体外受同源和异源乳头瘤病毒E2蛋白调控,这些蛋白与共有反应序列(E2-RS)ACCN6GGT结合。当在上皮细胞系中检测11型HPV(HPV-11)的表达时,缺乏全长E2蛋白氨基末端反式激活结构域的HPV-11 E2-C蛋白总是抑制同源病毒E6启动子。相反,当新组成型增强子(CE)CE II缺失时,不仅基础启动子活性大幅降低,还会被完整的HPV-11 E2蛋白进一步抑制(M.T. Chin、T.R. Broker和L.T. Chow,《病毒学杂志》63:2967 - 2976,1989)。在此,我们证明,当从更强的替代启动子表达时,HPV-11 E2蛋白能有效抑制E6启动子,而与CE II无关。通过对HPV-11 E2-RS的四个高度保守拷贝以及相邻增强子 - 启动子元件进行系统的突变分析,我们发现最上游、启动子远端的E2-RS拷贝1在E6启动子调控中没有明显作用。同源HPV-11 E2蛋白的抑制作用通过E2-RS的三个启动子近端拷贝介导,但CE II的存在消除了全长E2蛋白对E2-RS拷贝2施加的抑制。当E2-RS启动子近端的两个(对于E2)或三个(对于E2-C)拷贝发生突变时,抑制作用减轻。我们特别证明,对E2-RS 3施加的抑制是由于宿主转录因子Sp1或Sp1样蛋白无法结合位于串联E2蛋白结合位点3和4上游1 bp处的非共有序列AGGAGG。相邻Sp1和E2-RS 3位点之间插入3 bp可使Sp1和E2蛋白都能结合,同时解除E2-RS 3介导的抑制。类似的突变分析表明,在CE II存在的情况下,与上游E2-RS 2附近GT-1基序结合的蛋白有助于消除E2蛋白的抑制作用。讨论了这些结果对病毒感染周期和病毒致癌过程中的意义。